These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 16142334

  • 1. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S.
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [Abstract] [Full Text] [Related]

  • 2. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S.
    Oncogene; 2007 Jan 11; 26(2):290-7. PubMed ID: 16847456
    [Abstract] [Full Text] [Related]

  • 3. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K, Yamamoto T, Yamada Y, Miyatake S, Nakagawa T, Tanigawa N.
    Oncol Rep; 2005 May 11; 13(5):891-7. PubMed ID: 15809755
    [Abstract] [Full Text] [Related]

  • 4. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
    Krieg A, Mahotka C, Krieg T, Grabsch H, Müller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD.
    Br J Cancer; 2002 Mar 04; 86(5):737-43. PubMed ID: 11875736
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.
    Végran F, Boidot R, Bonnetain F, Cadouot M, Chevrier S, Lizard-Nacol S.
    Endocr Relat Cancer; 2011 Dec 04; 18(6):783-92. PubMed ID: 21878572
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.
    Boidot R, Vegran F, Lizard-Nacol S.
    Int J Mol Med; 2009 Feb 04; 23(2):285-91. PubMed ID: 19148555
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y, Mowla SJ, Ziaee SA.
    Cancer Detect Prev; 2009 Feb 04; 32(4):308-13. PubMed ID: 19186007
    [Abstract] [Full Text] [Related]

  • 8. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
    Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD.
    Cancer Res; 1999 Dec 15; 59(24):6097-102. PubMed ID: 10626797
    [Abstract] [Full Text] [Related]

  • 9. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 11. An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.
    Zhu N, Gu L, Findley HW, Li F, Zhou M.
    Oncogene; 2004 Sep 30; 23(45):7545-51. PubMed ID: 15334064
    [Abstract] [Full Text] [Related]

  • 12. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
    Tröger A, Siepermann M, Mahotka C, Wethkamp N, Bülle H, Laws HJ, Escherich G, Janka-Schaub G, Göbel U, Dilloo D.
    Klin Padiatr; 2007 Sep 30; 219(3):127-33. PubMed ID: 17525905
    [Abstract] [Full Text] [Related]

  • 13. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 30; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H, Lu C, Mabuchi H, Tanigawa N.
    Cancer Lett; 2004 Dec 28; 216(2):147-55. PubMed ID: 15533590
    [Abstract] [Full Text] [Related]

  • 15. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
    Vasaturo F, Sallusti E, Gradilone A, Malacrino C, Nardo T, Avagnano G, Aglianò AM, Granato T, De Vincenzi B, Coppotelli G, Marzullo A, Soda G, Simonelli L, Modesti M, Scarpa S.
    Int J Oncol; 2005 Oct 28; 27(4):1005-11. PubMed ID: 16142317
    [Abstract] [Full Text] [Related]

  • 16. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.
    Urol J; 2009 Oct 28; 6(2):101-8. PubMed ID: 19472128
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y, Yamaguchi S, Hasegawa M, Nemoto T, Inoue M, Suzuki K, Hirokawa K, Kitagawa M.
    Leuk Res; 2004 May 28; 28(5):487-94. PubMed ID: 15068902
    [Abstract] [Full Text] [Related]

  • 18. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J, Huang CL, Liu D, Ueno M, Sumitomo S, Yokomise H.
    Int J Oncol; 2005 Nov 28; 27(5):1215-21. PubMed ID: 16211215
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, Antalffy BA, Blaney SM, Lau CC.
    Neuropathol Appl Neurobiol; 2007 Feb 28; 33(1):67-76. PubMed ID: 17239009
    [Abstract] [Full Text] [Related]

  • 20. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.